PFG
ABBV icon

PAX Financial Group’s AbbVie ABBV Stock Holding History

PAX Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$412K Sell
1,896
-339
-15% -$75.2K 0.07% 134
2025
Q4 		$511K Sell
2,235
-235
-10% -$53.5K 0.09% 120
2025
Q3 		$572K Buy
2,470
+95
+4% +$19.3K 0.1% 126
2025
Q2 		$441K Sell
2,375
-356
-13% -$66.2K 0.08% 158
2025
Q1 		$572K Buy
2,731
+592
+28% +$115K 0.1% 159
2024
Q4 		$380K Buy
2,139
+251
+13% +$46.1K 0.07% 191
2024
Q3 		$373K Buy
1,888
+289
+18% +$53.9K 0.07% 191
2024
Q2 		$274K Buy
1,599
+409
+34% +$67.8K 0.05% 210
2024
Q1 		$217K Buy
+1,190
New +$205K 0.04% 216

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAX Financial Group's ABBV Position: Q1 2026 in Review

PAX Financial Group reduced its AbbVie (ABBV) stake by 15% in Q1 2026, selling an estimated $75.2K and leaving 1,896 shares worth $412K. The position accounts for 0.07% of the portfolio, ranked #134.

PAX Financial Group first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. The position peaked at $572K in Q1 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • PAX Financial Group held 1,896 shares of AbbVie worth $412K as of Q1 2026.
  • PAX Financial Group sold 339 AbbVie shares in Q1 2026, an estimated $75.2K.
  • AbbVie made up 0.07% of PAX Financial Group's portfolio in Q1 2026, its #134 holding.
  • PAX Financial Group first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
  • PAX Financial Group's AbbVie position peaked at $572K in Q1 2025.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on PAX Financial Group's 13F filing for Q1 2026, filed 27 Apr 2026.